Opioid Induced Constipation (OIC) Drug Market Report

China Opioid Induced Constipation (OIC) Drug Industry Market Research Report 2023-2029

  • POSTDATE：Aug 30, 2023
  • PAGES：174
  • REPORT CODE：GMM1766782
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Opioid Induced Constipation (OIC) Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Ono Pharmaceutical

    • Purdue Pharma

    • Valeant Pharmaceuticals International

    • Nektar Therapeutics

    • Theravance Biopharma

    • Ironwood Pharmaceuticals

    • SLA Pharma

    • Takeda Pharmaceutical Company Limited

    • Sucampo Pharmaceuticals

    • Daewoong Pharmaceutical

    • Pfizer

    • Progenics Pharmaceuticals

    • CB Fleet Company

    • Mundipharma International Limited

    • Cosmo Pharmaceuticals SA

    By Type:

    • Alvimopan

    • Methyl Naltrexone Bromide

    • Naldemedine

    • Lubiprostone

    • Other

    By Application:

    • Online Pharmacies

    • Hospital Pharmacies

    • Retail Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Opioid Induced Constipation (OIC) Drug Market Overview 2018-2029

    • 1.1 China Opioid Induced Constipation (OIC) Drug Industry Development Overview

    • 1.2 China Opioid Induced Constipation (OIC) Drug Industry Development History

    • 1.3 China Opioid Induced Constipation (OIC) Drug Industry Market Size (2018-2029)

    • 1.4 China Opioid Induced Constipation (OIC) Drug Market Analysis by Type from Production Side

      • 1.4.1 China Opioid Induced Constipation (OIC) Drug Production Volume, Production Value and Growth Rate of Alvimopan (2018-2029)

      • 1.4.2 China Opioid Induced Constipation (OIC) Drug Production Volume, Production Value and Growth Rate of Methyl Naltrexone Bromide (2018-2029)

      • 1.4.3 China Opioid Induced Constipation (OIC) Drug Production Volume, Production Value and Growth Rate of Naldemedine (2018-2029)

      • 1.4.4 China Opioid Induced Constipation (OIC) Drug Production Volume, Production Value and Growth Rate of Lubiprostone (2018-2029)

      • 1.4.5 China Opioid Induced Constipation (OIC) Drug Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • 1.5 China Opioid Induced Constipation (OIC) Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Opioid Induced Constipation (OIC) Drug Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

      • 1.5.2 China Opioid Induced Constipation (OIC) Drug Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

      • 1.5.3 China Opioid Induced Constipation (OIC) Drug Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • 1.6 China Opioid Induced Constipation (OIC) Drug Market Analysis by Region

      • 1.6.1 North China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Opioid Induced Constipation (OIC) Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Opioid Induced Constipation (OIC) Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Opioid Induced Constipation (OIC) Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Opioid Induced Constipation (OIC) Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Opioid Induced Constipation (OIC) Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Opioid Induced Constipation (OIC) Drug Industry Development

    Chapter 3 Opioid Induced Constipation (OIC) DrugIndustry Chain Analysis

    • 3.1 Opioid Induced Constipation (OIC) Drug Industry Chain

    • 3.2 Opioid Induced Constipation (OIC) Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Opioid Induced Constipation (OIC) Drug Market

    • 3.3 Opioid Induced Constipation (OIC) Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Opioid Induced Constipation (OIC) Drug Market

    Chapter 4 China Opioid Induced Constipation (OIC) Drug Market, by Type

    • 4.1 China Opioid Induced Constipation (OIC) Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Opioid Induced Constipation (OIC) Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate of Alvimopan

      • 4.5.2 China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate of Methyl Naltrexone Bromide

      • 4.5.3 China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate of Naldemedine

      • 4.5.4 China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate of Lubiprostone

      • 4.5.5 China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate of Other

    Chapter 5 China Opioid Induced Constipation (OIC) Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Opioid Induced Constipation (OIC) Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Online Pharmacies

      • 5.5.2 China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Hospital Pharmacies

      • 5.5.3 China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Retail Pharmacies

    Chapter 6 China Opioid Induced Constipation (OIC) Drug Market, by Region

    • 6.1 China Opioid Induced Constipation (OIC) Drug Production Volume and Production Value, by Region

    • 6.2 China Opioid Induced Constipation (OIC) Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Opioid Induced Constipation (OIC) Drug Market Analysis

    • 7.1 North China Opioid Induced Constipation (OIC) Drug Market, by Type

    • 7.2 North China Opioid Induced Constipation (OIC) Drug Market, by Application

    Chapter 8 Central China Opioid Induced Constipation (OIC) Drug Market Analysis

    • 8.1 Central China Opioid Induced Constipation (OIC) Drug Market, by Type

    • 8.2 Central China Opioid Induced Constipation (OIC) Drug Market, by Application

    Chapter 9 South China Opioid Induced Constipation (OIC) Drug Market Analysis

    • 9.1 South China Opioid Induced Constipation (OIC) Drug Market, by Type

    • 9.2 South China Opioid Induced Constipation (OIC) Drug Market, by Application

    Chapter 10 East China Opioid Induced Constipation (OIC) Drug Market Analysis

    • 10.1 East China Opioid Induced Constipation (OIC) Drug Market, by Type

    • 10.2 East China Opioid Induced Constipation (OIC) Drug Market, by Application

    Chapter 11 Northeast China Opioid Induced Constipation (OIC) Drug Market Analysis

    • 11.1 Northeast China Opioid Induced Constipation (OIC) Drug Market, by Type

    • 11.2 Northeast China Opioid Induced Constipation (OIC) Drug Market, by Application

    Chapter 12 Southwest China Opioid Induced Constipation (OIC) Drug Market Analysis

    • 12.1 Southwest China Opioid Induced Constipation (OIC) Drug Market, by Type

    • 12.2 Southwest China Opioid Induced Constipation (OIC) Drug Market, by Application

    Chapter 13 Northwest China Opioid Induced Constipation (OIC) Drug Market Analysis

    • 13.1 Northwest China Opioid Induced Constipation (OIC) Drug Market, by Type

    • 13.2 Northwest China Opioid Induced Constipation (OIC) Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Ono Pharmaceutical

        • 14.1.1 Ono Pharmaceutical Company Profile

        • 14.1.2 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Purdue Pharma

        • 14.2.1 Purdue Pharma Company Profile

        • 14.2.2 Purdue Pharma Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Valeant Pharmaceuticals International

        • 14.3.1 Valeant Pharmaceuticals International Company Profile

        • 14.3.2 Valeant Pharmaceuticals International Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Nektar Therapeutics

        • 14.4.1 Nektar Therapeutics Company Profile

        • 14.4.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Theravance Biopharma

        • 14.5.1 Theravance Biopharma Company Profile

        • 14.5.2 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Ironwood Pharmaceuticals

        • 14.6.1 Ironwood Pharmaceuticals Company Profile

        • 14.6.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 SLA Pharma

        • 14.7.1 SLA Pharma Company Profile

        • 14.7.2 SLA Pharma Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Takeda Pharmaceutical Company Limited

        • 14.8.1 Takeda Pharmaceutical Company Limited Company Profile

        • 14.8.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Sucampo Pharmaceuticals

        • 14.9.1 Sucampo Pharmaceuticals Company Profile

        • 14.9.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Daewoong Pharmaceutical

        • 14.10.1 Daewoong Pharmaceutical Company Profile

        • 14.10.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Pfizer

        • 14.11.1 Pfizer Company Profile

        • 14.11.2 Pfizer Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Progenics Pharmaceuticals

        • 14.12.1 Progenics Pharmaceuticals Company Profile

        • 14.12.2 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 CB Fleet Company

        • 14.13.1 CB Fleet Company Company Profile

        • 14.13.2 CB Fleet Company Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Mundipharma International Limited

        • 14.14.1 Mundipharma International Limited Company Profile

        • 14.14.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Cosmo Pharmaceuticals SA

        • 14.15.1 Cosmo Pharmaceuticals SA Company Profile

        • 14.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Market Performance

        • 14.15.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Opioid Induced Constipation (OIC) Drug Industry Research Conclusions

    • 15.2 Opioid Induced Constipation (OIC) Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Opioid Induced Constipation (OIC) Drug Industry Market Size (2018-2029)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume, Production Value and Growth Rate of Alvimopan (2018-2029)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume, Production Value and Growth Rate of Methyl Naltrexone Bromide (2018-2029)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume, Production Value and Growth Rate of Naldemedine (2018-2029)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume, Production Value and Growth Rate of Lubiprostone (2018-2029)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Opioid Induced Constipation (OIC) Drug Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • Figure China Opioid Induced Constipation (OIC) Drug Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure China Opioid Induced Constipation (OIC) Drug Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure North China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2018-2029

    • Figure Opioid Induced Constipation (OIC) Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Opioid Induced Constipation (OIC) Drug Market Share by Type in 2018

    • Figure China Opioid Induced Constipation (OIC) Drug Market Share by Type in 2023

    • Figure China Opioid Induced Constipation (OIC) Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate of Alvimopan (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate of Methyl Naltrexone Bromide (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate of Naldemedine (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate of Lubiprostone (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Market Share by Application in 2018

    • Figure China Opioid Induced Constipation (OIC) Drug Market Share by Application in 2023

    • Figure China Opioid Induced Constipation (OIC) Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Online Pharmacies (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Table China Opioid Induced Constipation (OIC) Drug Production Volume by Region (2018-2023)

    • Table China Opioid Induced Constipation (OIC) Drug Production Volume Share by Region (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Volume Share by Region (2018-2023)

    • Table China Opioid Induced Constipation (OIC) Drug Production Value by Region (2018-2023)

    • Table China Opioid Induced Constipation (OIC) Drug Production Value Share by Region (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Production Value Share by Region (2018-2023)

    • Table China Opioid Induced Constipation (OIC) Drug Sales Volume by Region (2018-2023)

    • Table China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Region (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Region (2018-2023)

    • Table China Opioid Induced Constipation (OIC) Drug Sales Value by Region (2018-2023)

    • Table China Opioid Induced Constipation (OIC) Drug Sales Value Share by Region (2018-2023)

    • Figure China Opioid Induced Constipation (OIC) Drug Sales Value Share by Region (2018-2023)

    • Table North China Opioid Induced Constipation (OIC) Drug Production Volume by Type (2018-2023)

    • Table North China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Figure North China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Table North China Opioid Induced Constipation (OIC) Drug Sales Volume by Application (2018-2023)

    • Table North China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Opioid Induced Constipation (OIC) Drug Production Volume by Type (2018-2023)

    • Table Central China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Table Central China Opioid Induced Constipation (OIC) Drug Sales Volume by Application (2018-2023)

    • Table Central China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Table South China Opioid Induced Constipation (OIC) Drug Production Volume by Type (2018-2023)

    • Table South China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Figure South China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Table South China Opioid Induced Constipation (OIC) Drug Sales Volume by Application (2018-2023)

    • Table South China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Table East China Opioid Induced Constipation (OIC) Drug Production Volume by Type (2018-2023)

    • Table East China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Figure East China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Table East China Opioid Induced Constipation (OIC) Drug Sales Volume by Application (2018-2023)

    • Table East China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Opioid Induced Constipation (OIC) Drug Production Volume by Type (2018-2023)

    • Table Northeast China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Opioid Induced Constipation (OIC) Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Opioid Induced Constipation (OIC) Drug Production Volume by Type (2018-2023)

    • Table Southwest China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Opioid Induced Constipation (OIC) Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Opioid Induced Constipation (OIC) Drug Production Volume by Type (2018-2023)

    • Table Northwest China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Opioid Induced Constipation (OIC) Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Opioid Induced Constipation (OIC) Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Opioid Induced Constipation (OIC) Drug Sales Volume Share by Application (2018-2023)

    • Table Ono Pharmaceutical Company Profile

    • Table Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Purdue Pharma Company Profile

    • Table Purdue Pharma Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Valeant Pharmaceuticals International Company Profile

    • Table Valeant Pharmaceuticals International Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Nektar Therapeutics Company Profile

    • Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Theravance Biopharma Company Profile

    • Table Theravance Biopharma Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Ironwood Pharmaceuticals Company Profile

    • Table Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table SLA Pharma Company Profile

    • Table SLA Pharma Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Limited Company Profile

    • Table Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Sucampo Pharmaceuticals Company Profile

    • Table Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Daewoong Pharmaceutical Company Profile

    • Table Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Progenics Pharmaceuticals Company Profile

    • Table Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table CB Fleet Company Company Profile

    • Table CB Fleet Company Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Mundipharma International Limited Company Profile

    • Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)

    • Table Cosmo Pharmaceuticals SA Company Profile

    • Table Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US